
About Amicus Formulations India Private Limited
Data last updated:
Amicus Formulations India Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 November 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2014PTC096589.
The company has an authorised share capital of ₹8 Cr and a paid-up capital of ₹7.76 Cr. It is led by directors Vamshider Joganpally Rao and Sushanth Yellapantula.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H No:8 – 2 – 686/6/D/5 Road No:12 Banjara Hills, Hyderabad, Telangana, India – 500034.
Court records list 1 case involving the company, including 1 filed against it. The company has 29 deals on record (23 rights issues, 4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹5.1 Cr; the latest was in February 2019.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website genesysbiologics.com.
Company details
Contact details
Amicus Formulations India Private Limited's registered office is in Hyderabad, Telangana. Its website is genesysbiologics.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressH No:8 – 2 – 686/6/D/5 Road No:12 Banjara Hills, Hyderabad, Telangana, India – 500034
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Amicus Formulations India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Amicus Formulations India is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Amicus Formulations India Private Limited, buy the company report.
Financials of Amicus Formulations India Private Limited
FY 2024 filings availableAmicus Formulations India Private Limited reported revenue of ₹1,200 (down 96% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 74% over five years, including a 96% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹1,200 | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Amicus Formulations India Private Limited, buy the company report.
Board of directors of Amicus Formulations India Private Limited
Amicus Formulations India has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sushanth Yellapantula Also directs: Fonte Advisory LLP, Liberty Ridge Capital Advisory Services LLP | Additional Director | 16 Apr 2024 | 2 Years 7 Months | Current |
| Vamshider Joganpally Rao | Director | 28 Nov 2014 | 11 Years 11 Months | Current |
Auditor
Amicus Formulations India Private Limited is audited by Anant Rao & Mallik for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Anant Rao & Mallik | FY 2023 | 006266S |
Shareholding
The shareholding of Amicus Formulations India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Amicus Formulations India Private Limited, buy the company report.
Deals & funding
Amicus Formulations India Private Limited has 29 deals on record (23 rights issues, 4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹5.1 Cr; the latest was in February 2019.
Deals on record (5 of 29)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Oct 2018 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: an individual |
| Sep 2017 | Rights issue | ₹4.92 Cr | Investors: 4 individuals Seller: 4 individuals |
| Jul 2017 | Rights issue | ₹1.14 Cr | Investors: 3 individuals |
| Jun 2017 | Rights issue | ₹37 Lakh | Investors: an individual |
To see the full deal history of Amicus Formulations India Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Amicus Formulations India Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Hyderabad | Insolvency matter | Filed against the company by Zydus Healthcare Limited | Disposed |
To see the full case history of Amicus Formulations India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Amicus Formulations India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Amicus Formulations India has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
GST
No GST registration is on our record for Amicus Formulations India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Amicus Formulations India Private Limited has 4 board changes on record since 2014: 2 appointments and 2 cessations. The latest: Krishna Yeachuri ceased to be Director on 17 Apr 2024.
Frequently asked questions
Amicus Formulations India is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 November 2014 (12+ years old) and is registered under CIN U24232TG2014PTC096589.
Amicus Formulations India has 2 current directors:
- Sushanth Yellapantula - Additional Director
- Vamshider Joganpally Rao - Director
The latest financial statements of Amicus Formulations India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Amicus Formulations India is U24232TG2014PTC096589. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amicus Formulations India has 1 court case on record: 1 filed against it.
Amicus Formulations India was incorporated on 28 November 2014, making it 12+ years old. It is registered with the Registrar of Companies, Hyderabad.
Amicus Formulations India has 29 deals on record (23 rights issues, 4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹5.1 Cr; the latest was in February 2019.
Krishna Yeachuri ceased to be Director on 17 Apr 2024. Sushanth Yellapantula was appointed as Additional Director on 16 Apr 2024. Rajender Juvvadi Rao ceased to be Director on 20 Nov 2020. Amicus Formulations India has 4 board changes on record in total.
Amicus Formulations India can be reached through the website genesysbiologics.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Amicus Formulations India is at H No:8 – 2 – 6866D5 Road No:12 Banjara Hills, Hyderabad, Telangana, India – 500034.

